These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13009389)

  • 21. Ristocetin and the Staphylococcus; observations of effects and side-effects in seventeen cases of staphylococcic pneumonia.
    CALVY GL; SCHUMACHER LR
    J Am Med Assoc; 1958 Jul; 167(13):1584-6. PubMed ID: 13563145
    [No Abstract]   [Full Text] [Related]  

  • 22. Some properties of magnamycin; a new antibiotic.
    TANNER FW; ENGLISH AR; LEES TM; ROUTIEN JB
    Antibiot Chemother (Northfield); 1952 Sep; 2(9):441-3. PubMed ID: 24542077
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns.
    LOWBURY EJ
    Lancet; 1957 Aug; 273(6990):305-10. PubMed ID: 13507637
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibiotic therapy of staphylococcus septicemia].
    BASTRUP-MADSEN P; NØRBY G
    Nord Med; 1952 Feb; 47(7):201-3. PubMed ID: 14910973
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic for staphylococcal infections.
    FINLAND M
    Med Clin North Am; 1958 Sep; 42(5):1179-94. PubMed ID: 13599740
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemistry and technology of antibiotic production; secretion, purification and chemical nature of antibiotics of the erythromycin group, of magnamycin; review of foreign periodical literature].
    TRAKHTENBERG DM
    Antibiotiki; 1956; 9(5):22-36. PubMed ID: 24544245
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnamycin. II. In vivo studies.
    ENGLISH AR; MULLADY HE; FITTS RA
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):94-8. PubMed ID: 24542283
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of antibiotic therapy on the emergence of resistant staphylococci in cutaneous bacterial infections.
    LIVINGOOD CS; GREER JE; BURNS RE; MENARD RR
    J Invest Dermatol; 1959 Apr; 32(4):485-93. PubMed ID: 13654833
    [No Abstract]   [Full Text] [Related]  

  • 29. Magnamycin. I. In vitro studies.
    ENGLISH AR; FIELD MF; SZENDY SR; TAGLIANI NJ; FITTS RA
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):678-88. PubMed ID: 24542158
    [No Abstract]   [Full Text] [Related]  

  • 30. Magnamycin: toxicity in experimental animals.
    GARDOCKI JF; P'AN SY; RAPUZZI AL; FANELLI GM; TIMMENS EK
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):55-62. PubMed ID: 24542279
    [No Abstract]   [Full Text] [Related]  

  • 31. Moniliasis associated with staphylococcal infection after antibiotic therapy.
    DEPAPE AJ
    Can Med Assoc J; 1959 Feb; 80(3):205-7. PubMed ID: 13618824
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation between in vitro studies and response to antibiotic therapy in staphylococcic bacteremia.
    ABBOUD FM; WAISBREN BA
    AMA Arch Intern Med; 1959 Aug; 104(2):226-33. PubMed ID: 13669776
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enterotoxicosis due to Micrococcus pyogenes aureus after sanclomycin treatment; cure by erythromycin].
    BERNAY P
    Arch Mal Appar Dig Mal Nutr; 1956 Oct; 45(10):276-7; discussion, 277-8. PubMed ID: 13373476
    [No Abstract]   [Full Text] [Related]  

  • 34. THE OBSTINATE Staphylococcus.
    Med World; 1956 Aug; 85(2):128-9. PubMed ID: 13358373
    [No Abstract]   [Full Text] [Related]  

  • 35. [Local action of various antibiotics and the specificity of this action].
    GUZZON V; ERCOLI N
    Boll Ist Sieroter Milan; 1951; 30(11-12):543-9. PubMed ID: 14934820
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intracerebral inoculation of Micrococcus in mice injected with penicillin: a possible method for the in vivo evaluation of antibiotics].
    PANISSET M; DOBIJA M
    Rev Can Biol; 1953 Nov; 12(3):404-10. PubMed ID: 13167750
    [No Abstract]   [Full Text] [Related]  

  • 37. The management of hospital-acquired staphylococcal infections.
    YOW EM; YOW MD; WOMACK GK; SAKUMA T; MONZON OT
    AMA Arch Intern Med; 1958 Dec; 102(6):948-59. PubMed ID: 13593902
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative sensitivity to antibiotics of skin staphylococci.
    HSIANG CM
    Chin Med J; 1958 Jul; 77(1):79-83. PubMed ID: 13573538
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapeutic effect of mycerin on experimental staphylococcal infection].
    FORSHTER KhK
    Antibiotiki (Mosc); 1959; 4(1):116-7. PubMed ID: 24545242
    [No Abstract]   [Full Text] [Related]  

  • 40. Hospital cross-infections with staphylococci resistant to several antibiotics.
    CLARKE SK; DALGLEISH PG; GILLESPIE WA
    Lancet; 1952 Jun; 1(6719):1132-5. PubMed ID: 14928602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.